Journal of Investigative and Clinical Dentistry
© Wiley Publishing Asia Pty Ltd
Edited By: Professor Lakshman Samaranayake, University of Queensland, Editor-in-Chief
Online ISSN: 2041-1626
AIMS AND SCOPE
Journal of Investigative and Clinical Dentistry (JICD) aims to publish quality, peer reviewed original research and topical reviews on all aspects of investigative and clinical dentistry and craniofacial research, including molecular studies related to oral health and disease. Although international in outlook, the Editors especially encourage papers from the Asia Pacific. The journal also aims to provide clinicians, scientists and students of dentistry with a knowledge transfer platform for rapid publication of reports through an international journal, which will be available free online until 2012.
Its scope, therefore, is broad, inclusive and international, but with a particular focus on Asia Pacific. The journal accepts the following types of manuscripts: laboratory investigations, clinical investigations, full reviews and mini reviews. The Editors welcome manuscripts in the following key thematic areas in oral and maxillofacial sciences:
• Community Dentistry and Oral Epidemiology
• Conservative Dentistry
• Dental Biomaterials
• Dental Pedagogy
• Endodontics and Traumatology
• Implant Dentistry
• Oral Biosciences
• Oral and Maxillofacial Surgery
• Oral Medicine
• Oral Microbiology
• Oral Pathology
• Oral Radiology
• Oral Rehabilitation
• Periodontology and Periodontal Medicine
EDITORIAL REVIEW AND ACCEPTANCE
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.
SUBMISSION OF MANUSCRIPTS
Manuscripts should be submitted online at http://mc.manuscriptcentral.com/jicd.
Authors must supply an email address as all correspondence will be by email. Two files should be supplied: the covering letter and the manuscript (in Word or rich text format (.rtf)). The covering letter should be uploaded as a file not for review.
All articles submitted to the Journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.
Types of papers
The following categories of papers are accepted by JICD.
Please note that Case Reports are no longer accepted.
(i) Original papers,
(ii) Review articles (full reviews and mini reviews),
(iii) Short communications,
Please see below for the submission details of each category of paper and note carefully the instructions.
Organization and format
To optimize the automated pre-editing and tagging process specific to the manuscript article type, manuscripts must be supplied in the correct format and with the appropriate section and heading. Please attend to the following details:
• Submissions should be double-spaced.
• All margins should be at least 30 mm.
• All pages should be numbered consecutively in the top right-hand corner, beginning with the title page.
• Do not use Enter at the end of lines within a paragraph.
• Turn the hyphenation option off; include only those hyphens that are essential to the meaning.
• Specify any special characters used to represent non-keyboard characters.
• Take care not to use l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for β (Greek beta).
• Use a tab, not spaces, to separate data points in tables. If you use a table editor function, ensure that each data point is contained within a unique cell (i.e. do not use carriage returns within cells).
Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files should be uploaded. Digital images supplied only as low-resolution files cannot be used.
Further instructions are available at the submission site.
Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. This must be stated in the covering letter.
The covering letter must also contain an acknowledgment that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author's contribution to the paper is to be quantified.
If tables or figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Tokyo 2004), available at http://www.wma.net/e/policy/b3.htm. The Journal retains the right to reject any manuscript on the basis of unethical conduct of either human or animal studies.
All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used).
Clinical trials should be reported using the CONSORT guidelines available at www.consort-statement.org. A CONSORT checklist should also be included in the submission material.
Journal of Investigative and Clinical Dentistry encourages authors submitting manuscripts reporting from a clinical trial to register the trials in any of the following free, public clinical trials registries: www.clinicaltrials.gov, http://clinicaltrials-dev.ifpma.org, http://isrctn.org. The clinical trial registration number and name of the trial register will then be published with the paper.
Authors are required to disclose all sources of institutional, private and corporate financial support for their study. Suppliers of materials (for free or at a discount from current rates) should be named in the source of funding and their location (town, state/county, country) included. Other suppliers will be identified in the text. If no funding has been available other than that of the author's institution, this should be specified upon submission. Authors are also required to disclose any potential conflict of interest. These include financial interests (for example patent, ownership, stock ownership, consultancies, speaker's fee,) or provision of study materials by their manufacturer for free or at a discount from current rates. Author's conflict of interest (or information specifying the absence of conflicts of interest) and the sources of funding for the research will be published under a separate heading entitled “Conflict of Interest and Sources of Funding Statement”. See www.icmje.org/#conflicts for generally accepted definitions.
Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.
COPYRIGHT, LICENSING and ONLINE OPEN
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.
FAQs about the terms and conditions of the standard copyright transfer agreements (CTA) in place for the journal, including terms regarding archiving of the accepted version of the paper, are available at: CTA Terms and Conditions FAQs
OnlineOpen – ‘Gold road’ Open Access
OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons licence. In addition, authors of OnlineOpen articles are permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication. With OnlineOpen the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access, known as ‘gold road’ open access.
OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND)
For more information about the OnlineOpen license terms and conditions click here
Self-archiving Under Wiley’s CTA terms authors may deposit certain versions of their articles in repositories. Details are available from the Wiley Online Library website.
Note to NIH grantees: Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grantholders to PUBMED Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate
STYLE OF THE MANUSCRIPT
Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org
Spelling. The Journal uses US spelling and authors should therefore follow the latest edition of the Merriam–Webster’s Collegiate Dictionary.
Units. All measurements must be given in SI or SI-derived units.
Abbreviations. Abbreviations should be used sparingly – only where they ease the reader's task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Trade names. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
Genetic nomenclature. Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).
PARTS OF THE MANUSCRIPT
Manuscripts should be presented in the following order:
(i) title page,
(ii) abstract and key words,
(iii) text consisting of Introduction, Material and Methods, Results and Discussion,
(iv) Conflict of Interest and Sources of Funding Statement,
(vii) figure legends,
(viii) tables (each table complete with title and footnotes) and
Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
TYPES OF PAPERS
The length of these (including references, tables, figure legends and appendices) should not exceed 6000 words and must follow the format given above.
Full reviews. It is desirable that authors first electronically submit an outline of their proposed article for evaluation by the Editor-in-Chief (firstname.lastname@example.org). The outline should be no more than two, double-spaced pages in size 12 font, in which the authors describe in bullet point format the objectives and contents of the report. Once the proposal has been evaluated, the authors will be informed of the results of the Editor’s initial consideration of their proposal. Reviews should NOT take on the IMRAD style, but must contain an abstract, introduction, the review proper, the conclusions and references.
Minireviews. Minireviews are expected to be focused discussions of defi ned topics. A topical outline should be provided to the Editor-in-Chief for approval prior to submission of the completed minireview manuscript in Rapid Review.
Minireviews are not expected to be comprehensive reviews of the literature but rather focused discussions of specific topics. A standard title page should be provided. This is followed by an abstract of 100 words or less and then the text of the minireview, which should not exceed 12 double-spaced manuscript pages in length, exclusive of tables, figures, photographs, and references. Up to a total of three tables, figures, or photographs, may be included. References should be limited to no more than 30.
These manuscripts are to provide an opportunity for the presentation of preliminary or brief observations that do not warrant a full paper. The manuscript should be prepared as is an Original Article, except they may be no more than 10 double-spaced pages in not less than size 12 font (including title-page, abstract, text, references and tables/figures).
Letters to the Editor are intended to provide an opportunity to discuss issues related to previously published original articles, case reports or short communications and should not be used for the presentation of the authors’ preliminary data from their own investigations. Letters should be no more that two double-spaced pages, in no less that size 12 font, including references.
Please note that Case Reports are no longer accepted by the Journal.
ORGANIZATION OF THE TEXT
The title page should contain:
(i) the title of the paper,
(ii) the full names of the authors and
(iii) the addresses of the institutions at which the work was carried out together with
(iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
The title should be short, informative and contain the major key words. Do not use abbreviations in the title. A short running title (less than 40 characters) should also be provided.
Abstract and key words
All articles must have an abstract that states in 200 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. For Original Articles, divide the abstract with the headings: Aim, Methods, Results, Conclusions. The abstract should not contain abbreviations or references.
Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html
Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Methods, Results and Discussion (IMRAD style).
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors' industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
The Vancouver system of referencing should be used (examples are given below). In the text, references should be cited using superscript Arabic numerals in the order in which they appear.
In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list.
Names of journals should be abbreviated in the style used in Index Medicus.
Authors are responsible for the accuracy of the references.
We recommend the use of a tool such as Reference Manager for reference management and formatting. Reference Manager reference styles can be searched for here: http://www.refman.com/support/rmstyles.asp
1 Botticelli D, Berglundh T, Lindhe J. Hard-tissue alterations following immediate implant placement in extraction sites. J Clin Periodontol 2004; 10: 820–8.
2 Taubman MA, Ebersole JL, Smith DJ. Association between systemic and local antibody and periodontal diseases. In: Genco RJ, Mergenhagen SE, ed. Host-parasite interactions in periodontal diseases. Washington, DC: Am Soc Microbiol, 1982: 283–98.
Cancer-Pain.org [homepage on the Internet]. Association of Cancer Online Resources, New York c2000-01 [updated 16 May 2002; cited 9 Jul 2002]. Available from: http://www.cancer-pain.org/
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Do not include reference citations in tables and table legends.
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Figures should be sized to fit within the column (83 mm), intermediate (125 mm) or the full text width (171 mm). Magnifications should be indicated using a scale bar on the illustration.
Line figures should be sharp, black and white graphs or diagrams, drawn professionally or with a computer graphics package. Lettering must be included and should be sized to be no larger than the journal text.
Figure legends. Type figure legends on a separate page. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Do not include reference citations in figures and figure legends.
Visit the Journal of Investigative and Clinical Dentistry home page at http://www.jicd.org for more information, and Wiley-Blackwell’s web pages for submission guidelines and digital graphics standards at http://authorservices.wiley.com/bauthor and http://authorservices.wiley.com/bauthor/illustration.asp
Author Services enables authors to track their article, once it has been accepted, through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated emails at key stages of production so they do not need to contact the production editor to check on progress. Visit http://authorservices.wiley.com/ for more details on online production tracking and for a wealth of resources, including FAQs and tips on article preparation, submission and more.
This journal is available online at Wiley Online Library. Visit wileyonlinelibrary.com to search the articles and register for table of contents and e-mail alerts.
Journal of Investigative and Clinical Dentistry is covered by our Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive.
For the full list of terms and conditions, see http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms. Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://authorservices.wiley.com/bauthor/onlineopen_order.asp
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
For questions concerning copyright, please visit our Author Services website on http://authorservices.wiley.com/bauthor/
It is essential that corresponding authors supply an email address to which correspondence can be emailed while their article is in production.
Word files of edited articles will be sent for checking via email, and should be returned to the Publisher. It is essential that these files are checked carefully, as the cost of changes made at a later stage may be charged to the author. Full instructions on how to correct and return the file will be attached to the email.
Notification of the URL from where to download a Portable Document Format (PDF) typeset page proof, associated forms and further instructions will be sent by email to the corresponding author. The purpose of the PDF proof is a final check of the layout, and of tables and figures. Alterations other than the essential correction of errors are unacceptable at PDF proof stage. The proof should be checked, and approval to publish the article should be emailed to the Publisher by the date indicated, otherwise, it may be signed off on by the Editor or held over to the next issue.
A minimum of 50 offprints will be provided upon request, at the author’s expense. These paper offprints may be ordered online. Please visit http://offprint.cosprinters.com/, fill in the necessary details and ensure that you type information in all of the required fields. If you have queries about offprints please email email@example.com
EDITORIAL OFFICE ADDRESS
Journal of Investigative and Clinical Dentistry
University of Queensland
200 Trubot Street